Fig. 9
From: Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Exogenous VEGF-A decreased the expression of Kir4.1 in rMC-1 cells. a Cell viability of rMC-1 cells treated with rh-VEGF-A. b Protein expression of Kir4.1 in rMC-1 cells treated with rh-VEGF-A. c Cell viability of rMC-1 cells treated with glyoxal with or without ranibizumab. Data are expressed as mean ± SE (n = 12 in [a, c], n = 4 in [b], *P < 0.05). N: normal control; G: rMC-1 cells treated with 1 mM glyoxal; G + R: rMC-1 cells treated with glyoxal and ranibizumab